Onconetix secures $6.25M through PIPE of Series E convertible preferred and warrants

Onconetix, Inc.

• Sold 7,813 shares of Series E convertible preferred stock at $1,000 stated value per share.
• Series E convertible at $3.8576 per share; warrants to purchase 2,025,223 common shares included.
• Total gross proceeds of approximately $6.25 million from institutional investors.
• Ownership limitation set at 4.99%; registration rights agreement granted for underlying shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.